In October, LIFEBRIDGE Medizintechnik of Ampfing, Germany won FDA approval for the B2T heart-lung machine. The portable unit is designed to be percutaneously (fem-fem) connected to the patient for quick circulatory support during acute cardiac failure. Last year this system won a red dot product design award.
The unique level of automation allows the system to be ready for use within 5 – 10 minutes and guides the trained user intuitively through the menu on the integrated display in five steps. The Lifebridge reaches a blood flow of up to 6 l/min and is powered by a mains voltage of 110/220V AC. For mobile operation, the system can be switched to battery power for a period of up to 2.5 hours. It contains an automatic seven stage air safety system preventing air embolisms.
Some technical specs:
Blood flow: Up to 6 liters/minute (active drainage, depending on cannulation) Gastransfer: Adult according A.A.M.I Set-up time: Only a few minutes through semi-automatic priming and de-bubbling Max. Support time: 6h Air emboli protection: 7-fold air elimination system Display: Touch screen to guide the user and to monitor the system status Power supply (mains): 110/230 Volt AC or 24 Volt DC Power supply (battery): 2 hours + 30 minutes Weight: 17,5 kg (38 lb) without base station Dimensions: 24 inch x 17 inch x 14 inch (W/H/D) without base station
More from MTB Europe…
Product page: The LIFEBRIDGE B2T…
Press release: Novel Cardio-Pulmonary Support Device LIFEBRIDGE from Germany gains FDA Clearance… (.doc)
red dot design award announcement…
